Dicerna more than doubles following IPO

|About: Dicerna Pharmaceuticals, Inc. (DRNA)|By:, SA News Editor

After pricing its 6M-share IPO at $15, Dicerna Pharmaceuticals (DRNA) opened at $30 and is now trading at $31.90, up 113%.

The cancer/liver disease drug developer currently has a market cap of $530M.

Prospectus, IPO preview